Chantel Murrah, DPM
Podiatrist · Ogden, UTNPI 1093791311
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $218, 2.2 times the $100 reported in 2021. That places this record below the midpoint for podiatrist clinicians in UT, where the typical reported total is $963.
Across 30 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$113
- Solventum Corporation$59
- Mimedx Group, Inc.$55
- Orthofix Medical, Inc.$50
- KCI USA, Inc.$48
- Nevro Corp.$36
- plus $217 from 12 others
What the payments were for
- Food & beverage$577100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $113 |
| Solventum Corporation | 3 | $59 |
| Mimedx Group, Inc. | 2 | $55 |
| Orthofix Medical, Inc. | 2 | $50 |
| KCI USA, Inc. | 3 | $48 |
| Nevro Corp. | 1 | $36 |
| Biocomposites Inc | 2 | $32 |
| Organogenesis Inc. | 2 | $29 |
| Treace Medical Concepts, Inc. | 1 | $20 |
| Surgenex LLC | 1 | $19 |
| AbbVie | 1 | $18 |
| Globus Medical | 1 | $17 |
| GRT US Holding, Inc. | 1 | $15 |
| Innovation Technologies Inc | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| Polynovo North America LLC | 1 | $13 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$577 in reported general payments places this provider in the 35th percentile of 59 podiatrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Silver Sulfadiazine | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Ogden
- David GraffOgden$39K
- Jason LucasOgden$6K
- Paul ClaytonOgden$963
- Kevin WalkerOgden$54
- Jason BruseLayton$203K
- Anna HronekSalt Lake City$82K
- Michele CarrDraper$56K
- Clark LarsenMurray$16K
- Kelly HamblinWest Jordan$13K
- Mikol AndersonSalt Lake City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.